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ABSTRACT
AdeR–AdeS is a two-component regulatory system,
which controls expression of the adeABC efflux
pump involved in Acinetobacter baumannii multidrug
resistance. AdeR is a response regulator consisting
of an N-terminal receiver domain and a C-terminal
DNA-binding-domain. AdeR binds to a direct-repeat
DNA in the intercistronic region between adeR and
adeABC. We demonstrate a markedly high affinity
binding between unphosphorylated AdeR and DNA
with a dissociation constant of 20 nM. In addition,
we provide a 2.75 A˚ crystal structure of AdeR DNA-
binding-domain complexed with the intercistronic
DNA. This structure shows that the 3 and  hair-
pin formed by 5–6 interacts with the major and
minor groove of the DNA, which in turn leads to
the introduction of a bend. The AdeR receiver do-
main structure revealed a dimerization motif me-
diated by a gearwheel-like structure involving the
D108F109-R122 motif through cation  stack interac-
tion. The structure of AdeR receiver domain bound
with magnesium indicated a conserved Glu19Asp20-
Asp63 magnesium-binding motif, and revealed that
the potential phosphorylation site Asp63OD1 forms
a hydrogen bond with Lys112. We thus dissected
the mechanism of how AdeR recognizes the inter-
cistronic DNA, which leads to a diverse mode of re-
sponse regulation. Unlocking the AdeRS mechanism
provides ways to circumvent A. baumannii antibiotic
resistance.
INTRODUCTION
Acinetobacter baumannii (A. baumannii) is now recognized
as serious nosocomial pathogen and is included as one of
the ESKAPE organisms (1). It is the most rapidly emerging
multidrug resistant Gram-negative nosocomial pathogen,
presenting mainly in pneumonia (particularly ventilator-
associated), meningitis, bacteremia and urinary tract infec-
tions (2). A. baumannii is resistant to most of the com-
monly used broad spectrum antimicrobials, presenting a
great challenge for the control and eradication of infections
(3).Multiple mechanisms have been described to be respon-
sible formultidrug resistance inA. baumannii, and of partic-
ular importance are the adaptive and mutational resistance
mediated by multidrug efflux pumps (4).
The Resistance-Nodulation-Cell Division (RND) super-
families of multidrug efflux pumps are mainly identified in
Gram-negative bacteria. These efflux pumps actively trans-
port a broad range of substrates, including antimicrobials,
out of the cell via a ternary complex that spans the inner
membrane, the periplasm and outer membrane (5). In A.
baumannii, three RND efflux pumps AdeABC, AdeFGH
and AdeIJK have been characterized to be tightly asso-
ciated with its multidrug resistance phenotype (6–8). Of
these, the AdeABC efflux conferred resistance to aminogly-
cosides, tetracyclines, fluoroquinolones, chloramphenicol,
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erythromycin, trimethoprim and tigecycline (6,9,10). The
AdeABC efflux is genetically linked and tightly controlled
by the AdeR–AdeS two-component regulatory system (11).
Overproduction of the AdeABC efflux pump resulting in
decreased antimicrobial susceptibility was reported to be
caused by mutations in the adeRS genes (8,12–14). These
genes encode a classical two-component regulatory system
(TCS) consisting of a transmembrane sensor kinase and a
response regulator. TCS constitute the dominant bacterial
signaling system allowing them to adapt to environmen-
tal stimuli and display an intrinsic feedback mechanism to
survive under stress responses (15–17). Within AdeRS, the
histidine kinase AdeS senses environmental stimuli, while
the response regulator AdeR mediates the cellular response
by receiving a phosphoryl signal from AdeS and further
stimulates the expression of its target genes (15,17,18). It
is not only the production of the AdeABC efflux pump
that is mediated; it is proposed that AdeRS also regulates
genes required for biofilm formation and virulence, but in a
strain-specific manner (19). Therefore, two-component sys-
tems have been highlighted to potentially serve as an effec-
tive drug target, especially by targeting the response regula-
tor (16,20).
The response regulator AdeR consists of a CheY-like
receiver domain (RD, amino acid residues 1–127) and an
OmpR/PhoB type DNA binding domain (DBD, residues
138–247). Unlike most OmpR/PhoB type response regula-
tors which bind to the promoter region of their target genes
(21,22), AdeR recognizes a 10bp perfect direct-repeat DNA
sequence in a 168bp intercistronic region between adeR and
adeABC (23).
We combined biophysical and structural biology ap-
proaches to elucidate the mechanism by which AdeR rec-
ognizes this intercistronic DNA and how this is regulated
through its receiver domain. The structural details of the
AdeR receiver domain and theAdeRDNAbinding domain
in complex with the intercistronic regionDNA are provided
and complemented with mutagenesis and thermodynamic
analysis. We further validated the assembly of full length
AdeR in complex with the DNA segment in solution with
small angle X-ray scattering. The involvement of AdeR reg-
ulation related to itsmutations in clinical isolates of themul-
tidrug resistantA. baumannii and its potential in antimicro-
bial strategy are discussed.
EXPERIMENTAL PROCEDURES
Cloning and site-directed mutagenesis
All strains were grown in Lysogeny Broth (LB, 10 g/L tryp-
tone, 5 g/L yeast extract, and 10 g/L NaCl), unless oth-
erwise indicated. All genes were cloned from A. bauman-
nii ATCC19606, and Escherichia coli DH5 was used for
transformations. Constructs were generated to produce a
(1) full-length AdeR (AdeR FL), (2) the receiver domain
with linker sequence (AdeR RD, 1–137) and (3) the DNA
binding domain (AdeR DBD, 138–247). The AdeR FL,
AdeR RD and AdeR DBD were cloned into a modified
pET-28a vector with an N-terminal His6-tag and overex-
pressed in E. coli BL21 (DE3). Point mutations were gen-
erated through the PCR based site-directed mutagenesis
approach using the pET28a-AdeR FL construct (24). All
primers used are listed in Supplementary Table S1. Point
mutations were verified by sequencing.
Protein overexpression and purification
The E.coli BL21 (DE3) cells transformed with pET28-
AdeR FL, pET28-AdeR RD or pET28-AdeR DBD, were
grown to an OD600 of 0.7 at 28◦C in LB medium supple-
mented with 100 g/ml Kanamycin. After induction with
1 mM IPTG, cultures were incubated for 6 h prior to har-
vesting by centrifugation at 7000g (Beckman) and the re-
sulting cell pellets frozen at –20◦C. The frozen cell pellets
were resuspended in lysis buffer (50 mM Tris pH 8.0, 300
mM NaCl) and lysed by sonication at 4◦C. The lysate was
further centrifuged at 25 000g to remove cell debris.
Filtered lysate supernatant was loaded onto a Ni-NTA
column (Qiagen) pre-equilibrated with loading buffer and
washed with 5% elution buffer (25 mM Tris pH 8.0, 300
mM NaCl, 500 mM imidazole) followed by a 5–100% gra-
dient elution with an A¨KTA purifier system. The frac-
tions containing the eluted proteins were concentrated and
loaded on Superdex75 16/60 (GE Healthcare) size exclu-
sion chromatography column in 25 mM Tris pH 8.0, 150
mM NaCl, 10% glycerol. The main protein fractions were
concentrated for further usage. The protein concentration
was measured with a NanoDrop® spectrometer (Thermo
Fisher) using the extinction coefficient generated from Ex-
PASy ProtParam program (25). All the mutated AdeR pro-
teins followed the same purification approach as used for
the wild type.
Crystallization and data collection
The recombinant AdeR DBD protein was complexed with
the intercistronic DNA by mixing a 2:1 molar ratio of
AdeR DBD protein and the synthesized 25 bp DNA
(5′ TAAAGTGTGGAGTAAGTGTGGAGAA 3′), respec-
tively. The complex was further purified and buffer ex-
changed in 25mMTris pH 8.0, 150mMNaCl, 10% glycerol
using a Superdex75 16/60 (GE Healthcare) size-exclusion
chromatography column. For crystallization screening, the
purified complex was concentrated to 6–8 mg/ml and the
AdeR RD recombinant protein was concentrated to 15–
20 mg/ml. Crystallization screening was performed in a
392-well Hampton crystallization plate via sitting-drop va-
por diffusion at 20◦C against commercially available sparse
matrix screens (Molecular Dimensions and Hampton Re-
search). Selected hits were repeated and optimized manu-
ally with a crystallization drop containing 0.5 l of purified
protein plus 0.5 l of reservoir solution. The AdeR DBD–
DNA complex was crystallized in 0.2 M ammonium citrate
dibasic, 20% PEG 3350, and the AdeR RDwas crystallized
in 0.1 M sodium acetate trihydrate pH 4.6 and 2 M sodium
formate. AdeR RD in the following buffer 5.3 mM BeSO4,
35 mM NaF, 7 mM magnesium chloride, was crystallized
undermultiple conditions and the reported crystal structure
was discovered in 2.8M sodium acetate trihydrate at pH 7.0.
All the obtained crystals were soaked in cryoprotectant so-
lution containing the reservoir solution supplemented with
15–30% (v/v) glycerol and were flash-frozen in liquid ni-
trogen. X-ray diffraction data were collected on the Beam-
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Table 1. X-ray data collection and refinement statistics
Crystal AdeR RD AdeR RDMg AdeR DBD&DNA complex
Data collection
Spacegroup P3221 P3221 P1
a, b, c (A˚) 65.3, 65.3, 50.3 64.8, 64.8, 50.0 55.5, 71.4, 78.4
, ,  (◦) 90, 90, 120 90, 90, 120 102, 105, 102
Resolution (A˚) 37.58–1.40 (1.45–1.40) 28.04–1.60 (1.65–1.60) 43.82–2.75 (2.85–2.75)
Rmerge 0.115 (1.06) 0.045 (0.58) 0.106 (0.981)
Rmeas 0.118 0.046 0.124
Multiplicity 19.1 (15.5) 18.8 (14.0) 3.6 (3.6)
CC (1/2) 0.998 (0.831) 1 (0.915) 0.996 (0.601)
CC* 1 (0.953) 1 (0.978) 0.999 (0.867)
I/(I) 15.20 (1.92) 36.84 (3.31) 9.97 (1.29)
Completeness (%) 99.83 (98.37) 99.09 (96.05) 97.95 (97.83)
Wilson B-factor (A˚2) 16.60 23.54 58.79
Refinement
Total reflections 470 483 (37 348) 305 468 (21 852) 99 115 (10 127)
Unique reflections 24 660 (2412) 16 262 (1560) 27 914 (2791)
Rwork/Rfree 0.1884/0.2045 0.1758/0.2074 0.2462/0.2846
Number of atoms:
Macromolecules 930 958 6459
Water 105 76 77
Ligand 1
Average B-factor (A˚2) 29.00 36.09 49.05
Protein (A˚2) 28.20 35.84 49.28
Water (A˚2) 36.30 39.21 29.73
Ramachandran plot:
Favored/allowed (%) 97/3 96/4 93/7
Root-mean-square-deviation:
Bond lengths (A˚) 0.010 0.008 0.003
Bond angle (◦) 1.40 1.11 0.84
Statistics for the highest resolution shell are shown in parentheses.
lines BL18U and BL19U at Shanghai Synchrotron Radia-
tion Facility (SSRF) at 100 K.
Data processing and structure determination
X-ray diffraction data were integrated and scaled using
XDS suite (26). The structure of AdeR RD was deter-
mined with the maximum-likelihood molecular replace-
ment implemented in the Phaser program suite (27), using
the truncated structure of the Bacillus subtilis YycF/WalR
receiver domain (PDB: 2ZWM) as a search model. This
model had a sequence identity of 37%. The structure of the
AdeR RD in complex with Mg2+ was solved using the ob-
tained AdeR RD structure as the molecular replacement
search model. The structure of AdeR DBD in complex
with the intercistronic DNA was solved using the BALBES
molecular replacement platform. As a template model, the
sequence of the AdeR DBD. B. subtilis YycF/WalR DNA
binding domain (PDB: 2DIV) was selected (28,29). The
program COOT and PHENIX suite were used for further
manual model rebuilding and refinement (30,31). The crys-
tal structure of AdeR RD was finally solved at 1.4 A˚ in
spacegroup P3221 with the following cell dimensions a = b
= 65.3 A˚, c= 50.3 A˚ and =  = 90◦,  = 120◦. The struc-
ture was refined to a finalRwork/Rfree of 0.1844/0.2045. The
AdeR RD structure contains one molecule of AdeR RD
in the asymmetric unit, including the residues 10–129, and
105watermolecules. The structure ofAdeR RD in complex
with Mg2+ was solved at 1.6 A˚ resolution using similar cell
parameters as AdeR RD, and refined to a final Rwork/Rfree
of 0.1758/0.2074. The structure of the AdeR DBD, bound
to the intercistronic DNA complex was solved at 2.75 A˚ in
spacegroup P1 with a = 55.5 A˚, b = 71.4 A˚, c = 78.4 A˚ and
 =  = 102◦,  = 105◦. Global NCS and TLS parameters
were applied in the final refinement. The final structure was
refined to a Rwork/Rfree of 0.2462/0.2846. In total, there are
six AdeR DBDmolecules in the asymmetric unit with four
of them interacting with two 25bp DNA molecules, respec-
tively, and 77 water molecules were observed in the asym-
metric unit. All the data collection and refinement statistics
are summarized in Table 1.
Isothermal titration calorimetery
All the ITC experiments were performed with a Microcal
ITC200 calorimeter (GE Healthcare) at 25◦C. The protein
andDNA samples were buffer exchanged to 25mMTris pH
8.0, 150 mMNaCl, 10% glycerol, using size-exclusion chro-
matography prior to the experiments. The experiments were
conducted by injecting AdeR FL and AdeR FLR231A
protein (100–120M),AdeR DBDorAdeR FLR122A re-
combinant protein (200–250 M), into 10–14 Mof the 25
bp intercistronic region DNA. The injections contained 0.4
l for the first injection and 2 l for the second to 19th in-
jection, with 120 s intervals. All the ITC data were analyzed
with the supplementedMicrocal ITC data analysis package
under the one binding site mode.
Electrophoretic mobility shift assay
The electrophoretic mobility shift assay (EMSA) experi-
ments were carried out by applying the protocol of the
LightShift Chemiluminescent EMSA Kit (Thermo Scien-
tific) using biotin to detect protein–DNA interaction. The
nucleotides used for the EMSA had the same sequence as
those used for ITC but were labeled with biotin at their 5′
primer. The binding reactions were incubated in 10 l vol-
ume containing 1 pmol DNA and a protein concentration
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gradient in the binding buffer (10 mM Tris, 50 mM KCl,
1 mM DTT, 5% glycerol, pH 7.5) for 30 min. The reaction
mixtures were loaded onto a 5% native polyacrylamide gel
and separated in 0.5 × TBE at 100 V on ice, followed by
western blotting for biotin.
Small angle X-ray scattering
SAXS data were collected at the National Center for Pro-
tein Science, Shanghai, BL19U2 beamline in Shanghai Syn-
chrotron Radiation Facility (32). Measurements were car-
ried out at 293K within a momentum transfer range from
0.04 to 0.45 A˚−1. Protein or Protein-DNA complex sam-
ples were measured under batch mode at solute concen-
trations in 25 mM Tris pH 8.0, 150 mM NaCl, 5% glyc-
erol buffer. Twenty frames were collected for each sample
and no measurable radiation damage was detected. Data
processing was performed by following the procedure de-
scribed previously (33). Briefly, buffer subtraction and ex-
trapolation were performed with the program PRIMUS;
the Guinier region was evaluated with the Guinier approx-
imation. The Rg (radius of gyration), I0 (forward scatter-
ing), Dmax (maximum particle dimension) and the distance
distribution function P(r) were determined with the pro-
gram GNOM (34). The rigid body and the ab initio mod-
eling were performed with the SASREF, DAMMIF and
DAMAVER program respectively under the ATSAS pack-
age (35). CRYSOL from ATSAS package (35,36) was used
to resolve the respective discrepancy of crystal structure
or models to the experimental data. The molecular weight
determination from SAXS data was performed using the
MoW2 online resource (37). SAXS data collection, analy-
sis and statistical details are summarized in Supplementary
Table S2.
RESULTS
Purification and thermodynamics of AdeR and its interaction
with the intercistronic region DNA
The full length AdeR protein consists of a receiver do-
main (RD) and an OmpR/PhoB-like DNA binding do-
main (DBD). To investigate the AdeR interaction with the
adeR-adeABC intercistronic DNA, we constructed and pu-
rified the recombinant full length AdeR (AdeR FL), as
well as the AdeR receiver domain (AdeR RD), and AdeR
DNA binding domain (AdeR DBD), separately (Figure
1A). The elution profile of size-exclusion chromatography,
calibrated with a standard protein mixture, revealed that
both AdeR FL and AdeR RD eluted as a dimer, while
AdeR DBD eluted as a monomer. The molecular weight
determination was cross-validated using small angle X-ray
scattering (Supplementary Table S2). A DNA fragment
consisting of the direct repeat sequence in the intercistronic
region between adeR and the RND efflux pump adeABC
was previously identified to interact with AdeR (23). Here,
we show that both AdeR FL and AdeR DBD alone can
bind a 25 bpDNA fragment containing this direct repeat se-
quence, forming a complex with a distinct chromatographic
behavior (Figure 1A). All the size-exclusion chromatogra-
phy purified samples were further analyzed by SDS-PAGE
followed with silver staining, to visualize both protein and
protein–DNA complex content (Figure 1B).
The interactions between AdeR FL or AdeR DBD and
DNA were quantified by isothermal titration calorimetery
(ITC) (Figure 1C and D). The dimer AdeR FL binds to the
intercistronic DNA in a markedly high-affinity interaction
with an equilibrium dissociation constant (Kd) of 20 nM, a
molar reaction enthalpy (H) of –21.9 kcal/mol, and en-
tropy of –38.1 cal/mol/deg (Figure 1C). The AdeR DBD
monomer was also able to interact with DNA, but with
an almost 100 times weaker interaction as indicated by the
Kd of 2.2 M, a molar reaction enthalpy H of –11.4
kcal/mol, and entropy of –12.4 cal/mol/deg (Figure 1D).
Crystal structure of the AdeR receiver domain
To explore why the binding affinity drops after removing
the receiver domain, we first solved the crystal structure of
AdeR RD at 1.4 A˚. The crystals presented one AdeR RD
molecule in the asymmetric unit (Table 1). AdeR RD has
the canonical ()5 repeat motif of the RR regulatory do-
main of two component systems. It has a helix-sheet-helix
sandwich with the five  strands forming a parallel  sheet
in the center surrounded by 1 and 5 on one side, and
2, 3, 4 on the other side (Figure 2A). AdeR RD assem-
bles as a compact dimer, generating a 2-fold symmetry. The
dimerization interface is formed by 4–5–5 with a buried
surface of 792.5 A˚2, determined using the PDBPISA server
(Figure 2A). Arg128 interacts via hydrogen bondswith both
Ala101 and Ile104 at both sides of the dimerization inter-
face (Figure 2B). In the core region of the dimerization in-
terface, Arg122 also forms strong hydrogen bonds with the
main chain at residue Phe109 and with the side chain of
Asp108, with bond lengths of 2.9 and 2.8 A˚, respectively.
Noteworthy, the benzene ring of Phe109 and the side chain
of Arg122 from one monomer form a gear wheel-like struc-
ture with the other monomer by forming a stack cation 
interaction. This structure is further stabilized by a hydro-
gen bond between Arg122 andAsp108 at both sides (Figure
2B). The key residues involved in this dimerization interface,
D108-F109-R122 are relatively conserved in A. baumannii
AdeR and are also found in other response regulators such
as the well-studied PhoP, where F109 is replaced by Y (Fig-
ure 2C).
To investigate the necessity of the receiver domain dimer-
ization for binding to the intercistronic DNA, we con-
structed multiple point mutations of residues involved in
AdeR dimer interactions. In size-exclusion chromatogra-
phy, the wild type AdeR FL was purified as a homoge-
nous dimer, while the D108A mutant presented predomi-
nantly as amonomer.Mutation to alanine of the key residue
R122, involved in the cation  interaction and in hydro-
gen bonds with D108 and F109, completely disrupted the
dimerization of AdeR (Figure 3A). In addition, ITC analy-
sis of DNA binding of this AdeRR122Amonomer demon-
strated a Kd of 1 M and a 2:1 stoichiometry with a molar
reaction enthalpy H of –10.6 kcal/mol and entropy of –
8.9 cal/mol/deg (Figure 3B). Notably the binding affinity
of AdeR FL R122A to the intercistronic DNA was con-
sistent with the AdeR DNA-binding domain on its own.
We further cross-validated the mutagenesis study by an
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Figure 1. Purification and thermodynamics of AdeR and its interaction with the intercistronic DNA. (A) Schematic view of AdeR and size exclusion
chromatography profile of AdeR full length (FL), receiver domain (RD), DNA binding domain (DBD). FLDNA and DBDDNA are the complex of
AdeR FL and DBD with the intercistronic DNA region, respectively. (B) Silver staining SDS PAGE of SEC purified AdeR samples from panel A, the
DNA band is highlighted. (C and D) The isothermal titration calorimetery of AdeR FL and AdeR DBD with the intercistronic DNA, the stoichiometry
(N), dissociation constant; enthalpy (H) and entropy (S) are denoted.
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Figure 2. Crystal structure of the AdeR receiver domain. (A) Crystal structure of the AdeR receiver domain dimer in different orientations. The AdeR
receiver domain consist of five  helices and five  stands forming a parallel  in between, the 4–5–5 motif is involved in the dimerization. (B) Detailed
interaction of residues involved in the AdeR receiver domain dimerization, the zoom-in view highlights D108, F109 and R122, forming a stable gear wheel
like structure. The density map of D108, F109 and R122 are shown with 2Fo – Fc = 3. (C) Sequence alignment of AdeR and the response regulator PhoP
receiver domain, secondary structures are denoted and the red star indicates the key residues involved in AdeR dimerization.
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Figure 3. Mutagenesis studies of AdeR receiver domain. (A) Size-exclusion chromatography analysis shows that the residues D108A and R122A could
disrupt the full length dimerization of AdeR. (B) Isothermal titration calorimetry experiment indicates the thermodynamics of AdeR full length R122A
mutation exhibits a similar profile as the AdeR DNA binding domain alone. (C) Electrophoretic mobility shift assay validates that D108A and F109A
interact with the intercistronic DNA similar to the AdeR DNA binding domain alone in a much lower affinity compared to wildtype AdeR full length.
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EMSA experiment. The mobility shift indicated that bind-
ing of AdeR FL to the intercistronic DNA was saturated
at around 2 M, while AdeR DBD, AdeR FL D108A and
AdeR FL F109A all exhibited similar binding but could
not be saturated even at 32 M (Figure 3C).
The interaction between the AdeR DNA binding domain and
the intercistronic DNA
AdeR binds to a 10 bp direct repeat DNA sequence
containing only a single random nucleotide in between
(AAGTGTGGAGNAAGTGTGGAG), present in the in-
tercistronic region between the genes encoding AdeR and
the efflux pump AdeABC. The crystal structure of re-
combinant AdeR DBD protein in complex with a 25 bp
DNA segment containing this repeat sequence was solved
at 2.75 A˚ in the P1 spacegroup. There were six monomers
of AdeR DBD, with four of them binding to two DNA
molecules in the asymmetric unit. The fifth AdeR DBD
molecule was trapped between twoDNAmolecules and the
last AdeR DBD molecule barely interacted with the DNA
(Supplementary Figure S1). The AdeR DBD forms a tradi-
tional OmpR/PhoB-like DNA binding domain with three
 helices and five  strands. Each AdeR DBD molecule
binds to the DNA with a contact surface of about 485 A˚2,
mainly through the 3 and  hairpin formed by 5 and 6
(Figure 4A). This binding of the AdeR DBD to the DNA
resulted in a 140 degrees bend towards the protein that is
similar to that seen with the response regulator PhoP (Fig-
ure 4A, left panel). The two AdeR DBDmonomers are not
perfectly aligned with the DNA strand direction (from 5′
to 3′), and hence they introduce a curvature of the DNA
strand (Figure 4A, right panel). In addition, the alignment
of AdeR DBD bound and unbound to DNA indicated a
conformational change of the 5 and 6 hairpin to adapt
to the minor groove, leading to and more residues trac-
ing of were traced of the flexible loop linked to the 3 he-
lix resulting from the DNA binding (Supplementary Fig-
ure S1). There are at least 10 hydrogen bonds and multiple
van der Waals interactions involved in the formation of the
AdeR DBD/DNA complex. The detailed interaction was
plotted with NUCPLOT as shown in Figure 4B (38). The
NH2 groups frompositive residues such asArg205, Arg215,
Arg231 and the OH group from Tyr235, the OG group
from Ser209, Ser212 and Thr171 form hydrogen bonds with
the backbone of the DNA helix. Specific interactions of
AdeR with the DNA including Arg231–3A’ (the primer in-
dicates the template strand), Arg205–4A’-5G’, Asp208–6T’,
Lys213–9G’ and Ser209–16C (Figure 4B), establish the ba-
sis for the recognition sequence specificity. The main 3
helix interacts with the major groove of the DNA, while
Arg231 from the  hairpin formed by 5 and 6 inserts into
the minor groove of the DNA (Figure 4C).
Overall, the AdeR DNA binding domain shows a rela-
tively low sequence identity with other response regulators
such as YycF and PhoB (15–20%) (Figure 5A). Interest-
ingly, the recognition sequence of AdeR is approximately
two times longer (10bp) than the one of YycF and PhoB
(5–6 bp). In addition, this sequence has a much shorter gap
between the two binding boxes, i.e. 1 bp with AdeR, and
5 bp with both YycF and PhoB (29). Despite this low se-
quence identity and the difference in the recognition DNA
sequence, the DNA binding motif 3 and the  hairpin
formed by 5 and 6 display high similarity and the key
residues involved in the DNA backbone interaction are still
conserved.
The AdeR DNA binding domain presents a structure
highly similar to YycF and PhoB with a RMS of 0.8 and
1 A˚, respectively, between matching C positions, while the
Arg231 residue from the  hairpin pitch is oriented in a
highly similar conformation allowing it to insert in the mi-
nor groove of the DNA (Figure 5B). Mutation of this key
residue to Ala completely abolishes the DNA binding as in-
dicated by ITC (Figure 5C) and EMSA experiments (Sup-
plementary Figure S2). Furthermore, a double mutation of
Arg205 and Arg215 from the 3 helix also results in the
loss of interaction between AdeR and its recognition target
(SupplementaryFigure S2). Indeed, themutation ofArg205
to alanine was also demonstrated in the B. subtilis PhoP
causing the failure of transcription activation (39).
Solution assembly of AdeR and its complex with the inter-
cistronic DNA
To elucidate the structure of AdeR and its complex with the
intercistronic DNA in solution, we continued its structural
characterization with small angle X-ray scattering supple-
mented with rigid body modeling. Highly monodisperse
preparations of AdeR FL, AdeR RD, AdeR DBD and
AdeR FL, AdeR DBD complexed with the intercistronic
DNA at different concentrations were used for SAXS mea-
surements (Figure 1A, Supplementary Table S2). Subse-
quently, the molecular weight of the measured samples
could be judged using the SAXSMoW2 package (37). This
indicated that the oligomerization assembly is consistent
with the SEC calculations as well as the binding studies via
ITC (Supplementary Table S2). The distance distribution
function and the Guinier region of the measured samples
were generated, and described the quality of the SAXSmea-
surements (Figure 6A and B). The SAXS experimental scat-
tering data of the AdeR RD and AdeR DBD binary com-
plexes with DNA revealed a compatible fit with the crys-
tal structures after adding the missing terminal residues or
simple SASREF modeling (Figure 6C). The AdeR FL and
DNA complex model were generated using the DAMMIF
and DAMAVER program in P1 symmetry; the AdeR RD
is in a head-to-head dimer while the AdeR DBD in com-
plex DNA is in a head-to-tail dimer form. Furthermore, the
crystal structures of the AdeR RD and AdeR DBD-DNA
complexes were successfully superpositioned onto the Ab
Initio model and agreed very well with a X2 value of 1.3
(Figure 6C) lending support that the crystal structure re-
flects the solution assembly.
Phosphorylation mimic and magnesium binding study of
AdeR
To investigate the activation mechanism of AdeR, we car-
ried out an aspartate phosphorylation mimic study of
AdeR. BeF3 is widely used as a phosphate analog in protein
aspartate phosphorylation especially with response regula-
tors such as the well characterized PhoP families (21,40).
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Figure 4. Crystal structure of AdeR DNA binding domain in complex with the intercistronic DNA. (A) Overall structure of AdeR DBD with DNA
complex. Two monomers of AdeR DBD binds with the two direct repeat intercistronic regions of DNA. The 3 and  hairpin formed by the 5 and 6
are involved in the binding of major and minor groove respectively. The density of the DNA in the left panel is shown in 2Fo – Fc = 1.5. (B) NUCPLOT of
the detailed interaction between one AdeR DBD and a single repeat of the intercistronic DNA. The dark blue represents the hydrogen bonds. (C) Detailed
main interaction between the AdeR DNA binding domain and the intercistronic DNA.
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Figure 5. Sequence alignment of AdeR DNA binding domain and mutagenesis study. (A) Sequence alignment of AdeR with the OmpR/PhoB like
response regulator YycF and PhoB DNA binding domains. The red star indicates the key positive residues involved in the protein and DNA interaction.
(B) Superposition of AdeR (Green) with YycF (Red) and PhoB (Blue) DNA binding domains with RMSD of 0.8 and 1.0 A˚ respectively; R231 is shown in
stick. (C) The R231Amutation in AdeR full length could abolish its interaction with the intercistronic DNA as shown by isothermal titration calorimetery.
In the case of response regulator VarR and RstA, supple-
menting with BeF3 can increase the binding affinity of the
response regulator to their target DNA fragments (21, 41).
However, the isothermal titration calorimetery experiment
of AdeR with the intercistronic DNA fragment in the pres-
ence of BeF3 andmagnesium had no influence on the AdeR
binding affinity to its target DNA (Figure 7A). This finding
corresponds with previous response regulator phosphoryla-
tionmimic studies (42) where themutation of aspartate into
asparagine showed no interference, the mutation of D63 to
E in AdeR also showed no affect in its interaction with the
target DNA as indicated by ITC (Figure 7B).
To validate whether BeF3 is not able to effectively mimic
the AdeR D63 phosphorylation or that phosphorylation
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Figure 6. Solution assembly of AdeR and its complex with the intercistronic region DNA. (A) Distance distribution function. (B) Guinier region analysis
of SAXS measure AdeR protein and its complex with DNA. C. The SAXS experiment scattering curve and their fit to the crystal structure of the AdeR
receiver domain (green top), AdeR DNA binding domain with DNA complex (red middle), the DAMMIF model of AdeR full length with DNA complex
(blue bottom). The AdeR receiver domain and the AdeR DNA binding domain complexed with DNA are superimposed onto the AdeR full length DNA
complex DAMMIF model.
indeed has no effect on AdeR interaction with its target
DNA,we crystallized theAdeR receiver domain in the pres-
ence of BeF3 and Mg2+. Although we could not observe
any density for BeF3 in the structure, we solved the crys-
tal structure of the AdeR receiver domain in complex with
onemagnesium ion to 1.6 A˚ (Table 1). The phosphorylation
site D63 is directly involved in the binding with the magne-
sium ion through its OD2 atom together with the Glu19,
Asp20 side chain, 1 water molecule and Lys65 backbone
(Figure 7C). The alignment of AdeR with or without mag-
nesium binding indicated a conformational switch of the
Asp20 residue (Figure 7C). The Glu, Asp and phosphory-
lation site D-forming pocket for the binding of magnesium
is highly conserved in the PhoP response regulator family
(Figure 2C). Surprisingly, the D63 OD1 atom that was ex-
pected to be phosphorylated forms a strong hydrogen bond
with Lys112 amino group with a distance of 2.7 A˚ (Figure
7C). This Lys112 is highly conserved between PhoP fami-
lies and AdeR (Figure 2C), however, the strong hydrogen
bond between Lys112 and the phosphorylation site was not
observed in other PhoP response regulator family members.
DISCUSSION
We provided here systematical structural insights into
AdeR, the key regulator of the AdeABC efflux pump in-
volved in multidrug resistance of A. baumannii. AdeR rec-
ognizes an intercistronic region direct repeatDNAsequence
located between the adeR and efflux pump adeABC operon.
The full length AdeR interacts with the intercistronic re-
gion with a dissociation constant of 20 nM, which is al-
most 100 times higher than theDNAbinding domain alone.
The conserved OmpR/PhoB-like DNA binding domain of
AdeR uses the long 3 helix and the  hairpin formed by
5 and 6 to bind the major and minor groove of the in-
tercistronic region, respectively. AdeR binding to the DNA
introduced a bend of ∼140◦ toward AdeR and a light cur-
vature along the DNA strand. Mutation from the pitch
residue R231A in the  hairpin, or R205A and R215A
from 3 could completely abolish this recognition. The re-
ceiver domain of AdeR dimerizes through the 4–5–5
motif D108F109 andR122, forming a stable gear wheel-like
structure by stack cation  interaction. Mutation of these
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Figure 7. Phosphorylation mimic and magnesium binding study of AdeR. (A) Isothermal titration calorimetry of AdeR FL interaction with the in-
tercistronic DNA in the presence of BeF3 and magnesium. (B) Isothermal titration calorimtery of AdeR FL D63E with the intercistronic DNA, the
stoichiometry (N), dissociation constant; enthalpy (H) and entropy (S) are denoted. (C) Alignment of AdeR bound (green) and unbound (wheat)
with magnesium ion (orange sphere). The phosphorylation site D63OD2 atom together with the Glu19, Asp20 side chain, Lys65 backbone and one water
molecule are involved in the binding of magnesium. The binding of magnesium causes a conformational change of Asp20. The D63OD1 atom forms a
strong hydrogen bond with the Lys112 amino group with a distance of 2.7 A˚.
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Figure 8. Structural alignment of the AdeR receiver domain (Green) with activated (Red) and unactivated PhoP (Grey). (A) PhoP Thr79 (AdeR Thr90)
and Tyr 98 (AdeR Phe109) are the switch residues involved in the conformational change during PhoP activation. The 4 and the loops between 4 and
4&5 are distinct with neither activated nor unactivated PhoP. (B) Alignment of the magnesium-binding motif of activated PhoP and AdeR in complex
with magnesium. The BeF3 (yellow stick) of PhoP has a severe clash with the Lys112 in AdeR, which forms a hydrogen bond with Asp63. Magnesium ions
are shown in spheres.
key residues disrupts the dimerization of AdeR and further
weakens its interaction with the intercistronic DNA. The
SAXS model indicated that the full length AdeR assembles
with the intercistronicDNA in a head-to-head arrangement
of the receiver domain, and head-to-tail positioning of the
DNA binding domain. This assembly may play a role in the
sequential binding of the response regulator to the two-half
target DNA sites, and affects the downstream gene activa-
tion through recruitment of the RNA polymerase  subunit
by the transaction loop (21,43).
The activation ofmost response regulators is mediated by
phosphoryl group transfer from its cognate histidine kinase,
however some of the atypical orphan response regulators
were also reported to use a phosphorylation independent
regulatory mechanism (18,22,44,45). In the canonical re-
sponse regulator such as PhoP, phosphorylation could sta-
bilize its dimerization to further increase the binding affin-
ity to DNA (18,46). AdeR D63 is aligned to the phospho-
rylation site of PhoP D52, and is thus predicted to be the
target phosphorylation residue (Figure 2C). A switch in-
volving two key residues, Thr79 in 4 and Tyr98 in 5, is
proposed as the major conformational change during acti-
vation of PhoP, reported as the common mechanism for all
response regulators (21,47,48). However, structural align-
ment of the AdeR receiver domain to activated and un-
activated PhoP indicates a dramatically different confor-
mation of AdeR 4 and its loop connection with 4&5
(Figure 8A). Nevertheless, the unphosphorylated and mag-
nesium bound AdeR switch residues Thr90 (PhoP Thr79)
and Phe109 (PhoP Tyr98) are consistent with the unacti-
vated conformation state (Figure 8A). More importantly,
Phe109 is directly involved in the dimerization of the AdeR
receiver domain (Figure 2B). A conformational change of
Phe109 to the activated state as in PhoP would disrupt
the cation  interaction between Phe109 and Arg122, and
would weaken the gear wheel-like structure, hence desta-
bilizing the AdeR dimer. The interaction of unphospho-
rylated AdeR to the intercistronic region DNA exhibits
a dissociation constant of 20nM, which is much higher
than other PhoP-like response regulators such as RstA
in an activated state (21). The high affinity binding of
AdeR to its target DNA sequence without phosphoryla-
tionmaymaintain a basal level of transcription of the efflux
pump in non-stimulated environment and establish a rapid-
reaction mode against antibiotic stress. Furthermore, struc-
tural analysis of AdeR in complex with magnesium indi-
cated that the magnesium-binding motif was conserved be-
tween the AdeR and PhoP family. However, the AdeR po-
tential phosphorylation atom Asp63OD1 can form a strong
hydrogen bond with the Lys112. The alignment of AdeR-
Mg and the activated PhoP-Mg-BeF3 structure revealed a
severe clash between the Lys112 and the BeF3 ion (Figure
8B). Therefore, the strong hydrogen bond interaction be-
tween Lys112 and Asp63OD1 may affect the phosphoryla-
tion by using an autoinhibition mechanism, as in the ubiq-
uitin ligase CBL which uses both an autoinhibition and
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a phosphorylation dependent activation mechanism (49).
The hydrogen bond between Lys112 and Asp63OD1 could
prevent non-specific phosphorylation and, hence, activation
ofAdeR from low-molecular-weight phosphate donors. Ac-
tivation of AdeR may specifically be initiated by its interac-
tionwithAdeS as this induces the conformational change of
Lys112 to release the phosphorylation site Asp63OD1. The
further structural investigation of AdeR and AdeS com-
plexes will definitely shine light on the activation mecha-
nism.
Besides D63, there are multiple potential phosphoryla-
tion D sites in AdeR that correlate with the expression of
the efflux pumpAdeABC (14,50). These residuesmay play a
direct or indirect role in the phosphorylation of AdeR. The
residue D20, for example, is occupied in the same pocket
as D63 and its mutation to E was found in a clinical iso-
genic A. baumannii strain and was demonstrated to en-
hance the efflux pump activity (13,50). We have now shown
that D20 is directly involved in the magnesium binding of
AdeR. Mutation to E may stabilize the interaction, and
hence enhance the AdeS phosphoryl transfer. Nonetheless,
additional phospho-proteomic effort will definitely help to
identify the AdeR aspartate phosphorylation profile and
enlighten the regulation mechanism of the AdeRS two-
component system. Besides occurring near the phospho-
rylation site, the mutational hot spots of AdeR from clin-
ical multidrug resistant isolates could also be located in the
receiver domain dimerization interface such as A91L and
P116L, or the DNAbinding interface i.e. E219A (11,14,51).
A simple BLAST analysis of the AdeR 10bp inter-
cistronic region recognition sequence resulted in more than
250 identical results in Acinetobacter spp. including ge-
nomic DNA, plasmids, and resistance islands, with many of
them containing multiple copies of AdeRS–AdeABC sys-
tems. The tight correlation of the AdeRS two-component
system with expression of the efflux pumpAdeABC, and its
specificity in A. baumannii, makes it a potential therapeutic
target against multidrug resistant A. baumannii. The mech-
anistic insight of the AdeR recognition of its target DNA
with the atomic resolution structure paves the way for the
structural based putative ligand binding site discovery, and
aid the in silico drug target screening for A. baumannii.
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